These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


796 related items for PubMed ID: 16620696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M, Krivan L, Semrád B.
    Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inappropriate shocks in patients receiving internal cardioverter-defibrillators for malignant ventricular arrhythmias.
    Prasad K, Kishore AG, Anderson MH, Ward DE, Rowland E, Gill JS, Camm AJ.
    Indian Heart J; 1997 Jun; 49(4):403-7. PubMed ID: 9358664
    [Abstract] [Full Text] [Related]

  • 8. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL, Hess M, Young J, Abraham WT.
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1002-9. PubMed ID: 15363071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ.
    Circulation; 2005 Jun 07; 111(22):2898-905. PubMed ID: 15927965
    [Abstract] [Full Text] [Related]

  • 12. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.
    Bhavnani SP, Coleman CI, White CM, Clyne CA, Yarlagadda R, Guertin D, Kluger J.
    Europace; 2008 Jul 07; 10(7):854-9. PubMed ID: 18495672
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1357-65. PubMed ID: 18387436
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P, Neves J, Sousa J, Fançoni J, da Silva N, Antunes E, Elvas L, Bernardo J.
    Rev Port Cardiol; 1997 Apr 08; 16(4):367-74, 351-2. PubMed ID: 9254126
    [Abstract] [Full Text] [Related]

  • 16. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD, Zhang J.
    Rev Cardiovasc Med; 2001 Apr 08; 2(2):61-72. PubMed ID: 12439383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Circulation; 2006 Feb 14; 113(6):776-82. PubMed ID: 16461817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.